• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA MAFG-AS1 通过调控 miR-125b-5p/SphK1 轴促进膀胱癌细胞的增殖、迁移和侵袭。

LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.

机构信息

Department of Urology, Jiaxing Second Hospital, No.1518 North Ring Road, Jiaxing City, 314000, Zhejiang Province, People's Republic of China.

出版信息

Hum Cell. 2021 Mar;34(2):588-597. doi: 10.1007/s13577-020-00470-3. Epub 2021 Jan 5.

DOI:10.1007/s13577-020-00470-3
PMID:33400245
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7900043/
Abstract

MAFG-AS1 is an oncogenic lncRNA in multiple types of cancer. However, its role in bladder cancer (BC) remains unclear. The present study aimed to investigate the function of MAFG-AS1 in BC. BC and paired non-tumor tissues were collected. Two BC cell lines HT01197 and HT-1376 were used. Dual luciferase activity assay, RT-qPCR, western blot, CCK-8, transwell invasion assay, and wound healing assay were performed. We found that MAFG-AS1 was significantly up-regulated in BC tissues and predicted a poor survival rate. MAFG-AS1 interacted with miR-125b-5p. However, the expression levels of MAFG‑AS1 and miR-125b-5p were not obviously correlated in BC tissues, and MAFG‑AS1 and miR-125b-5p did not regulate the expression of each other. Interestingly, we found that SphK1, a downstream target of miR-125b-5p, was negatively correlated with miR-125b-5p, while it was positively correlated with MAFG-AS1 across BC tissues. In addition, overexpression of MAFG‑AS1 upregulated the expression of SphK1 in BC cells, and attenuated the inhibitory effects of miR-125b-5p on the expression of SphK1. Functional assays showed that overexpression of MAFG‑AS1 promoted BC cell proliferation, migration, and invasion, while its effects were attenuated by overexpression of miR-125b-5p. Moreover, overexpression of miR-125b-5p inhibited BC cell proliferation, migration, and invasion, while its effects were alleviated by overexpression of SphK1. Taken together, our findings demonstrated that MAFG-AS1 has an oncogenic role in BC by regulating the miR-125b-5p/SphK1 axis. MAFG-AS1 might serve as a good diagnostic marker and a potential therapeutic target of BC.

摘要

MAFG-AS1 是多种类型癌症中的致癌 lncRNA。然而,其在膀胱癌(BC)中的作用尚不清楚。本研究旨在探讨 MAFG-AS1 在 BC 中的功能。收集 BC 组织和配对非肿瘤组织。使用两种 BC 细胞系 HT01197 和 HT-1376。进行双荧光素酶活性测定、RT-qPCR、western blot、CCK-8、Transwell 侵袭实验和划痕愈合实验。我们发现 MAFG-AS1 在 BC 组织中显著上调,并预测生存率较差。MAFG-AS1 与 miR-125b-5p 相互作用。然而,BC 组织中 MAFG-AS1 和 miR-125b-5p 的表达水平没有明显相关,并且 MAFG-AS1 和 miR-125b-5p 彼此不调节表达。有趣的是,我们发现 SphK1,miR-125b-5p 的下游靶标,与 miR-125b-5p 呈负相关,而与 across BC 组织中的 MAFG-AS1 呈正相关。此外,MAFG-AS1 的过表达上调了 BC 细胞中 SphK1 的表达,减弱了 miR-125b-5p 对 SphK1 表达的抑制作用。功能测定表明,MAFG-AS1 的过表达促进了 BC 细胞的增殖、迁移和侵袭,而过表达 miR-125b-5p 则减弱了其作用。此外,miR-125b-5p 的过表达抑制了 BC 细胞的增殖、迁移和侵袭,而过表达 SphK1 则减轻了其作用。总之,我们的研究结果表明,MAFG-AS1 通过调节 miR-125b-5p/SphK1 轴在 BC 中发挥致癌作用。MAFG-AS1 可能作为 BC 的良好诊断标志物和潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb69/7900043/910f6c064f7f/13577_2020_470_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb69/7900043/32f387b661c9/13577_2020_470_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb69/7900043/18feaf234d1e/13577_2020_470_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb69/7900043/b3c556819584/13577_2020_470_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb69/7900043/a92043bd4b59/13577_2020_470_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb69/7900043/1a9bcd847ae5/13577_2020_470_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb69/7900043/910f6c064f7f/13577_2020_470_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb69/7900043/32f387b661c9/13577_2020_470_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb69/7900043/18feaf234d1e/13577_2020_470_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb69/7900043/b3c556819584/13577_2020_470_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb69/7900043/a92043bd4b59/13577_2020_470_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb69/7900043/1a9bcd847ae5/13577_2020_470_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb69/7900043/910f6c064f7f/13577_2020_470_Fig6_HTML.jpg

相似文献

1
LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.长链非编码 RNA MAFG-AS1 通过调控 miR-125b-5p/SphK1 轴促进膀胱癌细胞的增殖、迁移和侵袭。
Hum Cell. 2021 Mar;34(2):588-597. doi: 10.1007/s13577-020-00470-3. Epub 2021 Jan 5.
2
LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.长链非编码 RNA MAFG-AS1 通过靶向 miR-143-3p/COX-2 轴促进膀胱癌的进展。
Pathobiology. 2020;87(6):345-355. doi: 10.1159/000509957. Epub 2020 Nov 25.
3
LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15.长链非编码 RNA MAFG-AS1 通过海绵吸附 MMP15 的 miR-339-5p 促进 NSCLC 细胞的迁移和侵袭。
Cell Biol Int. 2019 Apr;43(4):384-393. doi: 10.1002/cbin.11092. Epub 2019 Feb 6.
4
Long Noncoding RNA Suppresses Cell Proliferation, Migration, and Invasion of Bladder Cancer via / Axis.长链非编码 RNA 通过 / 轴抑制膀胱癌细胞增殖、迁移和侵袭。
DNA Cell Biol. 2022 Feb;41(2):179-189. doi: 10.1089/dna.2021.0637. Epub 2022 Jan 10.
5
Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.长链非编码 RNA DLX6-AS1 通过调节 miR-195-5p/VEGFA 信号通路促进膀胱癌进展。
Aging (Albany NY). 2020 Aug 3;12(16):16021-16034. doi: 10.18632/aging.103374.
6
YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.YY1 诱导的长非编码 RNA PSMA3 反义 RNA 1 作为竞争性内源性 RNA,通过调节程序性细胞死亡配体 1,促进膀胱癌细胞的活力并抑制其凋亡。
Bioengineered. 2021 Dec;12(2):9150-9161. doi: 10.1080/21655979.2021.1994907.
7
MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.微小 RNA-28-5p 通过靶向 SphK1 调节神经胶质瘤细胞的增殖、侵袭和迁移。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(15):6621-6628. doi: 10.26355/eurrev_201908_18551.
8
Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.沉默长链非编码 RNA 烟酰胺核苷酸转氢酶反义 RNA 1 通过靶向 miR-199a-5p 抑制甲状腺乳头状癌细胞增殖、迁移和侵袭并促进细胞凋亡。
Endocr J. 2021 May 28;68(5):583-597. doi: 10.1507/endocrj.EJ20-0353. Epub 2021 Mar 20.
9
LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15.长链非编码 RNA MAFG-AS1 通过调控 miR-339-5p/MMP15 促进乳腺癌的侵袭转移。
Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2838-2846. doi: 10.26355/eurrev_201904_17561.
10
Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.非编码 RNA MFI2-AS1 通过 miR-574-5p/MYCBP 轴促进结直肠癌细胞增殖、迁移和侵袭。
Cell Prolif. 2019 Jul;52(4):e12632. doi: 10.1111/cpr.12632. Epub 2019 May 16.

引用本文的文献

1
Curcumol targets the FTO/MAFG-AS1 axis to alleviate diabetic retinopathy epigenetic remodeling and nanodelivery-based microenvironment modulation.莪术醇靶向FTO/MAFG-AS1轴以减轻糖尿病视网膜病变的表观遗传重塑和基于纳米递送的微环境调节。
World J Diabetes. 2025 Jun 15;16(6):107017. doi: 10.4239/wjd.v16.i6.107017.
2
A redox-related lncRNA signature in bladder cancer.膀胱癌的氧化还原相关长非编码 RNA 特征。
Sci Rep. 2024 Nov 16;14(1):28323. doi: 10.1038/s41598-024-80026-9.
3
PAQR4 oncogene: a novel target for cancer therapy.PAQR4 癌基因:癌症治疗的新靶点。

本文引用的文献

1
Long noncoding RNA MAFG-AS1 promotes proliferation, migration and invasion of hepatocellular carcinoma cells through downregulation of miR-6852.长链非编码RNA MAFG-AS1通过下调miR-6852促进肝癌细胞的增殖、迁移和侵袭。
Exp Ther Med. 2019 Oct;18(4):2547-2553. doi: 10.3892/etm.2019.7850. Epub 2019 Aug 5.
2
miR-613 inhibits bladder cancer proliferation and migration through targeting SphK1.微小RNA-613通过靶向鞘氨醇激酶1抑制膀胱癌的增殖和迁移。
Am J Transl Res. 2017 Mar 15;9(3):1213-1221. eCollection 2017.
3
MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancer.
Med Oncol. 2024 May 20;41(6):161. doi: 10.1007/s12032-024-02382-w.
4
Correlation between long non-coding RNA MAFG-AS1 and cancer prognosis: a meta-analysis.长链非编码RNA MAFG-AS1与癌症预后的相关性:一项荟萃分析
Front Oncol. 2023 Dec 7;13:1286610. doi: 10.3389/fonc.2023.1286610. eCollection 2023.
5
LncRNA MAFG-AS1 is involved in human cancer progression.长链非编码 RNA MAFG-AS1 参与人类癌症进展。
Eur J Med Res. 2023 Nov 8;28(1):497. doi: 10.1186/s40001-023-01486-9.
6
Hypoxanthine guanine phosphoribosyltransferase 1, a target of miR-125b-5p, promotes cell proliferation and invasion in head and neck squamous cell carcinoma.次黄嘌呤鸟嘌呤磷酸核糖转移酶1(Hypoxanthine guanine phosphoribosyltransferase 1)是miR-125b-5p的一个靶点,它促进头颈部鳞状细胞癌的细胞增殖和侵袭。
Heliyon. 2023 Sep 19;9(9):e20174. doi: 10.1016/j.heliyon.2023.e20174. eCollection 2023 Sep.
7
Carcinogenic roles of MAFG-AS1 in human cancers.MAFG-AS1 在人类癌症中的致癌作用。
Clin Transl Oncol. 2024 Jan;26(1):52-68. doi: 10.1007/s12094-023-03246-x. Epub 2023 Jun 23.
8
ELK1 suppresses SYTL1 expression by recruiting HDAC2 in bladder cancer progression.ELK1 通过招募 HDAC2 抑制膀胱癌进展中的 SYTL1 表达。
Hum Cell. 2022 Nov;35(6):1961-1975. doi: 10.1007/s13577-022-00789-z. Epub 2022 Sep 15.
9
Long Non-Coding RNA MAFG-AS1 as a Potential Biomarker for Hepatocellular Carcinoma: Linkage with Tumor Features, Markers, Liver Functions, and Survival Profile.长链非编码RNA MAFG-AS1作为肝细胞癌的潜在生物标志物:与肿瘤特征、标志物、肝功能及生存情况的关联
Front Surg. 2022 May 17;9:848831. doi: 10.3389/fsurg.2022.848831. eCollection 2022.
10
SMAR1 inhibits proliferation, EMT and Warburg effect of bladder cancer cells by suppressing the activity of the Wnt/β-catenin signaling pathway.SMAR1 通过抑制 Wnt/β-catenin 信号通路的活性来抑制膀胱癌细胞的增殖、EMT 和瓦博格效应。
Cell Cycle. 2023 Jan;22(2):229-241. doi: 10.1080/15384101.2022.2112006. Epub 2022 Aug 18.
微小RNA-125b通过靶向鞘氨醇激酶1抑制膀胱癌的增殖和迁移。
Am J Transl Res. 2015 Nov 15;7(11):2346-54. eCollection 2015.